SCHEMBL4757209

SCHEMBL4757209

Cc1ccc(C(=O)Nc2ncc(S(C)(=O)=O)s2)cc1I

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 9/20 0.46
KMT2A Q03164 9/20 0.46
POLB P06746 3/20 0.46
RXFP1 Q9HBX9 2/20 0.46
RAB9A P51151 8/20 0.44
NPC1 O15118 7/20 0.44
PAX8 Q06710 1/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
FFAR2 O15552 1/20 0.43
KDM4E B2RXH2 2/20 0.41
GAA P10253 2/20 0.41
PKM P14618 1/20 0.41
ALDH1A1 P00352 2/20 0.41
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MTOR P42345 1/20 0.40
MAPK14 Q16539 2/20 0.40
LMNA P02545 3/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757111 0.84 MEN1 (0.47) MEN1KMT2APOLBRXFP1RAB9A
SCHEMBL10114568 0.83 TOP1 (0.44) MEN1KMT2APOLBRXFP1RAB9A
SCHEMBL4756248 0.83 MEN1 (0.43) MEN1KMT2APOLBRXFP1RAB9A
SCHEMBL4757155 0.82 NPC1 (0.59) MEN1KMT2APOLBRXFP1RAB9A
SCHEMBL4756952 0.81 RAB9A (0.57) MEN1KMT2ARXFP1RAB9ANPC1
SCHEMBL703520 0.80 FFAR2 (0.48) MEN1KMT2APOLBRAB9ANPC1
SCHEMBL4756983 0.80 FFAR2 (0.42) MEN1KMT2APOLBRXFP1RAB9A
SCHEMBL4757983 0.78 KDR (0.61) MEN1KMT2ARAB9ANPC1SMN1; SMN2
SCHEMBL4757157 0.78 STAT3 (0.49) MEN1KMT2APOLBRXFP1RAB9A
SCHEMBL703165 0.78 HSD17B1 (0.51) MEN1KMT2ARXFP1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC MEN1 4564/4885KMT2A 2303/4885POLB 4090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.